#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prostate cancer Juvenile idiopathic arthritis Philadelphia chromosome positive Marginal zone lymphoma recurrent Glomerulonephritis rapidly progressive Gastrooesophageal cancer Liver abscess Cryoglobulinaemia Vulval cancer Ichthyosis Cystic fibrosis gastrointestinal disease Arrhythmia Astrocytoma malignant Kidney transplant rejection Oesophageal achalasia More trials…

    Learn about Rare Diseases

    Niemann-Pick disease – Life with Disease Synovial sarcoma – Trials in Disease Toxic epidermal necrolysis – Life with Disease Acute respiratory distress syndrome – Diagnostics Toxic epidermal necrolysis – Trials in Disease Waldenstrom’s macroglobulinaemia recurrent – Diagnostics Pleomorphic leiomyosarcoma – Treatment Antisynthetase syndrome Mucopolysaccharidosis III – Basic Information Acquired haemophilia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    NORGESTIMATE Varenicline FLUORIDE L-Glutamic Acid Ceftolozane USNOFLAST Potassium Oxybate Valganciclovir Ucp4 OMEGA-3-ACID ETHYL ESTERS 90 Human Coagulation Factor Ii Aup1602-C Edoxaban Ertapenem Dexamethasone Elasomeran LY4170156 Magnesium Citrate Remifentanil Hydrochloride Bidridistrogene Xeboparvovec More therapies…

    Learn about Your Condition

    Intervertebral disc protrusion Organ donor Renal cancer recurrent Narcolepsy Growth hormone deficiency Glomerulonephritis acute Cardiovascular disorder Mast cell activation syndrome Altered state of consciousness Anal cancer recurrent Raynaud's phenomenon Allergic respiratory disease Injection site pain Haemorrhagic stroke Haemorrhage More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier De Versailles

Centre Hospitalier De Versailles

177 Rue De Versailles, Le Chesnay, Le Chesnay-Rocquencourt, 78150, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Effectiveness of Clesrovimab and Palivizumab for Preventing Severe RSV in Infants and Children at High Risk

    Not recruiting

    3 1 1
    Investigated Drugs:
    • CLESROVIMAB
    • Palivizumab
    • Sodium Chloride
    Czechia Finland France Germany Greece Hungary +3

  • Study on the Effects of Tobevibart and Elebsiran Compared to Bulevirtide for Patients with Chronic Hepatitis D Virus Infection

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatitis B
    • Hepatitis D
    Investigated Drugs:
    • Elebsiran
    • Tobevibart
    • Bulevirtide
    Belgium Bulgaria France Germany Italy The Netherlands +2

  • Study on the Safety and Effectiveness of MK-1654 for Preventing Respiratory Syncytial Virus (RSV) in Healthy Pre-Term and Full-Term Infants

    Not recruiting

    4 1 1
    Belgium Denmark Finland France Italy Poland +1

  • Study on Tobevibart and Elebsiran for Patients with Chronic Hepatitis D Virus Infection Not Responding to Bulevirtide Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatitis B
    • Hepatitis D
    Investigated Drugs:
    • Elebsiran
    • Tobevibart
    • Bulevirtide
    Austria France Germany Italy Romania Spain

  • Study of Quizartinib with Chemotherapy for Adults with Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Quizartinib Dihydrochloride
    • Idarubicin Hydrochloride
    • Daunorubicin Hydrochloride
    Austria Belgium Bulgaria Croatia Czechia France +9

  • Study on Continuing Nivolumab and Ipilimumab Treatment vs. Observation in Patients with Stage IV Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    France

  • Study on the Effectiveness of Enasidenib Mesilate in Patients with Myelodysplastic Syndrome with IDH2 Mutation

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Enasidenib Mesilate
    France Germany

  • Study Comparing Lenalidomide, Daratumumab, and Dexamethasone for Frail Patients with Untreated Multiple Myeloma Not Eligible for High-Dose Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Daratumumab
    • Dexamethasone
    • Lenalidomide
    Belgium France

  • Study of Teclistamab with Daratumumab or Lenalidomide for Elderly Patients with Newly Diagnosed Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Daratumumab
    • Teclistamab
    • Lenalidomide
    France

  • Study on the Effects of Methylprednisolone and Isavuconazonium Sulfate in Immunocompromised Patients with Acute Respiratory Failure of Unknown Cause

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Respiratory failure
    Investigated Drugs:
    • Isavuconazonium Sulfate
    • Methylprednisolone
    France
Previous Page
1 … 7 8 9 10 11 … 13
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!